Marco Davila, Senior Vice President, Translational Research at Roswell Park Comprehensive Cancer Center, shared Journal for ImmunoTherapy of Cancer’s post on LinkedIn, adding:
“Thank you, Journal for ImmunoTherapy of Cancer, for highlighting our work!
Proud of our team and grateful to our collaborators for making this study possible.
Excited to share our findings on CD83-directed CAR T cells as an alternative approach to targeting B-cell malignancies.
Read and let me know your thoughts/questions!”
Quoting Journal for ImmunoTherapy of Cancer’s post:
“New Article Alert:
Title: CD83 CAR T provides an alternative strategy to CD19-targeting in B cell malignancies
Authors: Brian Christopher Betts, Constanza Savid-Frontera, Shannon McSain, Kelly Walton, Eliese Maybee, Nolan Beatty, Payal Goala, Duna Massillon, Isaac M Spiegel, Shernan G Holtan, Frederick L Locke, Anne Eaton, Michael A Linden, Meredith L Stone, Renier J Brentjens, Marco L Davila
Congratulations to Dr. Marco Davila from Roswell Park Comprehensive Cancer Center and their team.”
Other articles about CAR T-cell therapy on OncoDaily.